Literature DB >> 20606448

Postictal transient hyperammonemia as an indicator of seizure disorder.

Kuan-Ting Liu1, Chi-Wei Lee, Shih-Chia Yang, I-Jeng Yeh, Tzeng-Jih Lin, Chen-San Su.   

Abstract

BACKGROUND AND
PURPOSE: Transient hyperammonemia can occur after episodes of seizure. To verify that transient hyperammonemia is a unique finding in seizure patients, we compared the change in blood ammonia concentration during the postictal period with that of other patients who suffered consciousness disturbances due to other disorders.
METHODS: We compared the results of a biochemical examination, including serum ammonia levels, between adult patients sent to the emergency department (ED) with seizure and those with other causes of consciousness disturbance.
RESULTS: Nineteen out of 31 patients with generalized epileptic seizures showed hyperammonemia at initial data measurement. Seventeen of these patients showed transient hyperammonemia. Only 10 patients with hepatic encephalopathy showed hyperammonemia, while none of the patients suffering from other causes of consciousness disturbance showed transient hyperammonemia within hours of arrival at the ED.
CONCLUSION: Transient hyperammonemia was observed in the majority of generalized tonic-clonic seizure patients examined in this study but not in those with other causes of consciousness disturbance. Because ammonia is checked in patients presenting with transient consciousness disturbance to the ED, with or without witness, transient hyperammonemia could be an indicator of recent epileptic seizure. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606448     DOI: 10.1159/000315034

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

1.  Postictal ammonia as a biomarker for electrographic convulsive seizures: A prospective study.

Authors:  Rawan Albadareen; Gary Gronseth; Patrick Landazuri; Jianghua He; Nancy Hammond; Utku Uysal
Journal:  Epilepsia       Date:  2016-06-01       Impact factor: 5.864

2.  Risk factors and outcome of hyperammonaemia in people with epilepsy.

Authors:  Umesh Vivekananda; Simona Balestrini; Angeliki Vakrinou; Elaine Murphy; Sanjay M Sisodiya
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

Review 3.  A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.

Authors:  Marzieh Jafari Fakharbad; Mohammad Moshiri; Mohammad Mehdi Ommati; Mehdi Talebi; Leila Etemad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-23       Impact factor: 3.195

Review 4.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11

5.  Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine.

Authors:  Yiqian Chen; Jingzhen Chen; Xiaorong Zhuang; Xingyu Chen; Jianqi Zeng; Ru Wang; Jiayin Miao
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.

Authors:  Cecilia Maldonado; Natalia Guevara; Cecilia Queijo; Raquel González; Pietro Fagiolino; Marta Vázquez
Journal:  Biomed Res Int       Date:  2016-02-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.